142 related articles for article (PubMed ID: 21749835)
1. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.
Ochi S; Kawasoe K; Abe M; Fukuhara R; Sonobe K; Kawabe K; Ueno S
Gen Hosp Psychiatry; 2011; 33(6):640.e1-2. PubMed ID: 21749835
[TBL] [Abstract][Full Text] [Related]
2. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.
Kato D; Kawanishi C; Kishida I; Furuno T; Matsumura T; Hasegawa H; Suzuki K; Hirayasu Y
Psychiatry Clin Neurosci; 2005 Aug; 59(4):504-7. PubMed ID: 16048458
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone.
Köhnke MD; Griese EU; Stösser D; Gaertner I; Barth G
Pharmacopsychiatry; 2002 May; 35(3):116-8. PubMed ID: 12107857
[TBL] [Abstract][Full Text] [Related]
5. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
7. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.
Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A
Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333
[No Abstract] [Full Text] [Related]
8. [Neuroleptic malignant syndrome in users of risperidone].
Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
[TBL] [Abstract][Full Text] [Related]
9. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
[No Abstract] [Full Text] [Related]
10. [Malignant neuroleptic syndrome and hyponatremia associated with risperidone poisoning].
Epelde Gonzalo F
An Med Interna; 2002 Jan; 19(1):50. PubMed ID: 11989083
[No Abstract] [Full Text] [Related]
11. [Neuroleptic malignant syndrome in users of risperidone].
Bonte-Mineur F; Geerlings CJ; Rietveld AP
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome in a patient with succinic semialdehyde dehydrogenase deficiency.
Neu P; Seyfert S; Brockmöller J; Dettling M; Marx P
Pharmacopsychiatry; 2002 Jan; 35(1):26-8. PubMed ID: 11819156
[TBL] [Abstract][Full Text] [Related]
13. [Malignant neuroleptic syndrome associated to risperidone].
Aguirre C; García Monco JC; Mendibil B
Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
[No Abstract] [Full Text] [Related]
14. [Neuroleptic malignant syndrome in users of risperidone].
van Bemmel T; Westendorp RG
Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
[No Abstract] [Full Text] [Related]
15. [Neuroleptic malignant syndrome in users of risperidone].
Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
[No Abstract] [Full Text] [Related]
16. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
17. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
Yamashita T; Fujii Y; Misawa F
J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
[No Abstract] [Full Text] [Related]
18. [Neuroleptic malignant syndrome in users of risperidone].
van Waarde JA; Kuiper J; Verwey B
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
[No Abstract] [Full Text] [Related]
19. Mutation involving cytochrome P450IID6 in two Japanese patients with neuroleptic malignant syndrome.
Kawanishi C; Shimoda Y; Fujimaki J; Onishi H; Suzuki K; Hanihara T; Sugiyama N; Kosaka K
J Neurol Sci; 1998 Sep; 160(1):102-4. PubMed ID: 9804127
[TBL] [Abstract][Full Text] [Related]
20. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
Ghio L; Fornaro G; Rossi P
J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
